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Regulation of mitochondrial activity allows cells to adapt to changing conditions and to 27 
control oxidative stress, and its dysfunction can lead to hypoxia-dependent pathologies, 28 
such as ischemia and cancer. Although cytochrome c phosphorylation—in particular, at 29 
tyrosine 48—is a key modulator of mitochondrial signaling, its action and molecular basis 30 
remain unknown. Here, we mimic phosphorylation of cytochrome c by replacing tyrosine 31 
48 with p-carboxy-methyl-L-phenylalanine (pCMF). The NMR structure of the resulting 32 
mutant reveals significant conformational shifts and enhanced dynamics around pCMF 33 
that could explain changes observed in its functionality: the phosphomimetic mutation 34 
impairs cytochrome c diffusion between respiratory complexes, enhances hemeprotein 35 
peroxidase and ROS scavenging activities and hinders caspase-dependent apoptosis. 36 
Our findings provide a framework to further investigate the modulation of mitochondrial 37 
activity by phosphorylated cytochrome c and to develop novel therapeutic approaches 38 
based on its pro-survival effects.  39 
 40 
SIGNIFICANCE STATEMENT 41 
Cell response to physiological changes and oxidative stress involves the modulation of 42 
mitochondrial metabolism. Its dysfunction favors the development of hypoxia-dependent 43 
pathologies, including ischemia and cancer. A key modulator of mitochondrial activity is 44 
cytochrome c, whose cell function is modulated by tyrosine phosphorylation. However, 45 
how such modification affects cytochrome c structure and function is barely known. Here, 46 
we report that a phosphomimetic mutant of cytochrome c exhibits enhanced dynamics, 47 
which could be responsible for the observed differences of cytochrome c functionality in 48 
oxidative stress and cell death. Thus, phosphorylation of cytochrome c becomes a target 49 
for further development of robust therapeutic approaches. 50 
\body  51 
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INTRODUCTION 52 
Oxidative phosphorylation (OxPhos) relies on the electron transport chain (ETC) to 53 
generate the membrane potential that drives ATP synthesis (1). Components of the ETC 54 
oxidize substrates to reduce molecular oxygen, thereby producing water. Nevertheless, 55 
around 2% of the electrons flowing across the ETC yield reactive oxygen species (ROS) 56 
(2). ROS are a source of oxidative stress and act as signaling molecules at low 57 
concentrations (3-5). Hindering redox reactions within the distinct ETC membrane 58 
complexes (complexes I to V) leads to enhanced ROS production (6). The activity of the 59 
ETC is tightly regulated by posttranslational modifications of its components, isoform 60 
swapping and modulation of the equilibria for the association of the membrane protein 61 
complexes into supercomplexes (3, 7). Such associations allow substrate channeling 62 
while modulating ROS production (3, 7).  63 
Oxidative stress response involves redox signals modulating protein phosphorylation (8). 64 
In the ETC, the major phosphorylation targets are NADH:UQ oxidoreductase, 65 
cytochrome c (Cc) and cytochrome c oxidase (CcO) (9). Besides being essential for 66 
oxidative respiration (Figure 1a), Cc acts as a redox regulatory protein within the 67 
mitochondrial intermembrane space (10). In addition, Cc aids to control ROS levels by 68 
oxidizing superoxide anions (11) and exhibiting peroxidase activity (12); the latter, 69 
however, also yields lipid peroxidation (13, 14). Furthermore, Cc plays a crucial role in 70 
programmed cell death, a process that is only in partially understood (15-21). In this 71 
context, a fraction of Cc binds and oxidizes cardiolipin (CL) at the internal mitochondrial 72 
membrane, thereby facilitating the release of unbound Cc to the cytoplasm (16, 17). In 73 
mammalian cells, extramitochondrial Cc interacts with apoptosis activating factor-1 74 
(Apaf-1) in the cytoplasm to spark the caspase proteolytic cascade (15). It has recently 75 
been shown that Cc can interact with several other proteins outside the mitochondria in 76 
humans and plants (18-21). The similarities between the Cc signaling networks in both 77 
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organisms suggest that key programmed cell death pathways are conserved along 78 
evolution (22). 79 
Cc phosphorylation is an alleged modulator of the mitochondrial cell death pathway (23, 80 
24). Its deregulation is believed to be related to the onset of neurological disorders and 81 
cancer (24). Phosphorylation of Cc is easily reversed by phosphatases, hampering the 82 
isolation of the modified protein from tissues (25). Tyr-to-Glu substitutions of Cc, 83 
designed to emulate Tyr48 phosphorylation, impair both the electron donation to CcO 84 
and the activation of caspase-9 mediated by Apaf-1 in vitro (26, 27). Notably, nitration of 85 
this residue also hinders the ability of Cc to activate Apaf-1 (28-30). Thus, these 86 
posttranslational modifications alter both mitochondrial and cytoplasmic functions of Cc. 87 
Tyr48 phosphorylation also affects the physical-chemical properties of Cc, such as its 88 
alkaline transition and midpoint reduction potential (E0) (27, 31). Understanding the origin 89 
of these effects and how they affect Cc activities requires to solve the 3D conformation 90 
of the phosphorylated species. However, deciphering the effects of Tyr48 91 
phosphorylation on the structure and dynamics of Cc is highly challenging because its 92 
reactivity towards phosphatases. Indeed, no atomic resolution structure has been 93 
reported for either phosphorylated Cc or any reliable mimic mutant.  94 
Here, we have elucidated the structure of a phosphomimetic Cc variant in which Tyr48 95 
is replaced by the synthetic, non-canonical amino-acid p-carboxy-methyl-L-96 
phenylalanine (pCMF). We show that such replacement induce local perturbations of the 97 
Cc structure and enhanced internal dynamics of the mutation surroundings. We used 98 
biochemical assays to show that the Y48pCMF mutation impairs Cc channeling between 99 
cytochrome bc1 (Cbc1) and CcO, enhances the peroxidase activity and induces an anti-100 





Phosphorylation of Tyr48 induces local structural changes in cytochrome c 105 
To understand how phosphorylation affects the structure of human Cc, we tackled the 106 
challenge of fully characterizing the phosphomimetic mutant Y48pCMF Cc in its reduced 107 
form, which is the redox state of Cc donating electrons to CcO in homeostasis and is 108 
essential for its apoptotic activity, since Cc becomes highly reduced upon its release 109 
from the mitochondria to the cytosol (32). Y48pCMF Cc maintains the overall secondary 110 
structure and global fold of wild-type (WT) Cc, as inferred from circular dichroism (CD) 111 
(Figure 1b) and 1H-15N heteronuclear single-quantum correlation (HSQC) nuclear 112 
magnetic resonance (NMR) spectra (Figure 1c), respectively. Also, the native heme 113 
axial coordination was preserved, as indicated by 1D 1H NMR data (Figure 1d). The 114 
NMR spectra of reduced Y48pCMF Cc were extensively assigned: triple-resonance 115 
experiments (Table S1) allowed us to detect and assign 91 backbone amide signals and 116 
the sequential connectivities for most residues of the protein. Aliphatic side-chain signals 117 
were assigned using 3D HBHA(CO)NH and 3D HCCH-TOCSY experiments, leading to 118 
the assignment of most (96.4%) of the side-chain proton resonances. The 15N-H 119 
resonance of pCMF48 was undetectable because the residue was not 15N-enriched. 120 
Four proline residues (Pro30, Pro44, Pro71 and Pro76) interrupt the sequential HN-HN 121 
connectivity. Additionally, in contrast to WT Cc, we could not detect the amide protons 122 
of the Thr49, Ala51, Gly56 and Ile57 residues. However, the WT spectra also only had 123 
four amide protons that could not be detected (Gly1, Glu21, Thr28 and Gly84) under 124 
similar experimental conditions. Further, in contrast to WT Cc, the signals from Asn31, 125 
Gly45 and Ser47 in pCMF48 Cc were significantly weaker than the rest. The largest 126 
chemical-shift perturbations for backbone amides induced by the modified residue at 127 
position 48 are confined to nearby residues (Figure S1).  128 
Assigning 1H resonances to the heme substituents and 1H (and 13C) signals to the 129 
aromatic side chains was required for analyzing additional 2D maps (i.e. COSY and 1H-130 
15N NOESY) (Table S1). Assignment of the CCC and C aromatic signals from 131 
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the pCMF48 side-chain required the acquisition of an aromatic 1H-13C HSQC spectrum 132 
recorded in a natural abundance of 13C (Figure 1e). The assignment of the pCMF48 133 
side-chain signals involved the complete assignment of the 2D 1H-15N NOESY.  134 
Numerous residues (Val20–Asn31, Thr40–Trp59 and Ile75–Glu90) displayed signals 135 
attributable to a second, minor protein conformation, which had a 1:10 ratio in intensity. 136 
Hereafter, only the major form was considered for structure calculations. 137 
We assigned a 96% of all the 1H signals for the major form. Structural information derived 138 
from 2D and 3D NOESY maps supported the presence of 5 -helical regions (labelled 139 
1 to 5) with typically strong HN-HN (i, i+1), medium-range H-HN (i, i+3) and H-HN 140 
(i, i+4), interresidual NOEs. These regions spanned the sequence stretches Val3–Lys13, 141 
Ala50–Asn54, Glu61–Glu69, Pro71–Tyr74 and Lys88–Thr102, resembling those in the 142 
NMR structure of reduced WT Cc (33). In total, we observed and assigned 2,176 143 
meaningful NOEs, corresponding to 20.8 relevant restraints per residue on average 144 
(Figure S2). The 71  and 71  dihedral angle constraints were derived from 15N, 13C’, 145 
13C, 13C and H chemical shifts, using TALOS+ (34). The heme moiety was included 146 
in the calculations as previously reported for WT cytochromes (35, 36), assuming an 147 
intact heme iron coordination as supported by the XAS spectroscopic data (see next 148 
section).  149 
Two-hundred structures were calculated by CYANA, and the twenty structures with the 150 
lowest target-function (TF) value were selected to form a representative family. The 151 
range of TF values was 0.38–0.98 Å2, highlighting the high accuracy between calculated 152 
and experimental distances. Further refinement of the 20 lowest TF structures involved 153 
restrained energy minimization and restrained molecular dynamics (RMD) computations. 154 
A final restrained energy minimization carried out on the structure with the lowest root-155 
mean square deviation (RMSD) to the average for each of the 20 trajectories. The overall 156 
quality of the 20 lowest TF ensemble was good, according to PROCHECK G-factor (37) 157 
7 
MolProbity clash-scores (38) and other structural quality indicators (Table S2). Most 158 
residues were in the Ramachandran plot favored regions, whereas Cys14, Cys17, His18, 159 
Val20, Lys37 and Asn70 were in the generously allowed ones, as also observed for the 160 
solution structure of WT Cc (33, 39). Cys14, Cys17 and His18 are covalently bonded to 161 
the heme moiety, thereby straining their backbone conformation, as already described 162 
for c-type cytochromes (35, 36). As an additional control, we performed 20 ns 163 
unrestrained molecular dynamics (MD) simulations of the final minimized conformers 164 
without any geometrical restraint. The RMSD for the main-chain atoms was about 1.55 165 
Å at the plateau, hardly drifting (0.122 pm ns–1), as expected for a stable structure 166 
(Figure S3). 167 
The overall fold of Y48pCMF Cc is very similar to that of the WT species (Figure S4), 168 
with RMSD values for the backbone nuclei of 1.67 ± 1.01 Å (Figure 2a,b). However, the 169 
two structures differ in the mutation-containing loop NY (residues 40–57; Figure 2b). 170 
This is consistent with the chemical-shift differences (Figure S1) and the RMSD between 171 
the NMR solution structure of WT Cc (PDB ID: 1J3S) (33) and the refined lowest-TF 172 
Y48pCMF Cc (Figure S5a). An increased dynamics in the loop NY has been recently 173 
observed in the G41S variant of Cc (41). The NY loop (also known as foldon V) and 174 
helix 2 constitute the less-stable folding unit of Cc (42). Unlike Tyr48 in the WT species, 175 
the pCMF48 residue presents a very low number of 1H-1H NOEs (Figure S2) and a high 176 
RMSD value within the family (Figure 2c and Figure S5b). A decrease in the number of 177 
detectable NOEs can generally be attributed to either a partial assignment of the residue 178 
or an increased internal mobility. In our case, the highly dynamic behavior of the pCMF48 179 
residue was confirmed from further analysis of internal motions within the ns-ps time 180 
scale (see below).  181 
Other regions of the Y48pCMF Cc structure that differed from that of WT Cc belong to 182 
the 19–36 G-loop (part of foldon II) and the 71–85 R-loop (foldon IV) comprising Met80 183 
and helix 4. The RMSD values for backbone atoms of residues from Val20 to Gly29 of 184 
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Y48pCMF Cc are higher (2.75 ± 1.50 Å) than those for the same residues of WT Cc 185 
(Figure S5a). In the second loop, the observed differences are mainly restricted to side 186 
chains. In fact, the RMSD values for backbone and heavy atoms are 1.18 ± 0.37 Å and 187 
1.77 ± 0.71 Å, respectively. Residues included in the R loop indeed displayed double 188 
conformation, suggesting the presence of conformational equilibria (Figure S5a). 189 
The ensemble of structures for Y48pCMF Cc is very precise, except for residues 190 
surrounding the mutation. The backbone RMSD to the mean is 0.89 ± 0.01 Å for the 191 
whole protein and drops to 0.53 ± 0.12 Å when the mutation surroundings are excluded 192 
(residues 40–57) (Figure S5b). As expected, the highest RMSD values correspond to 193 
the 40–57 ΩNY loop and the nearby residues Val20–Gly29 in loop ΩG, whose global 194 
backbone RMSD values were 1.79 ± 0.53 Å and 0.78 ± 0.23 Å, respectively. These 195 
segments also exhibited a larger conformational variability in their secondary structure 196 
elements along the MD trajectory (Figure S3b,c). High RMSD values along the Val20–197 
Gly29 stretch are typical in Cc homologs (35, 36). They are also consistent with NMR 198 
signals revealing secondary conformations for the His26–Pro30 stretch. Moreover, the 199 
nearby Asn31 amide signal is weak, suggesting a high mobility. Notably, all these 200 
residues contact the NY loop, comprising the Y48pCMF mutation. 201 
Further, the highest RMSD values mapped to the ΩNY loop. Consistently, signals from 202 
this region undergo a drastic reduction of their 1H-1H NOE cross-peaks. The intensities 203 
of the amide signals of Gly45 and Ser47 in Y48pCMF Cc were severely decreased, while 204 
those from Thr49, Ala51, Gly56 and Ile57 were undetectable. The R loop also contains 205 
some residues with high RMSD values (Figure S5b). The global RMSD value for 206 
backbone atoms of the 71–85 ΩR loop is equal to 0.76 ± 0.20 Å. Notably, the end of the 207 
R loop shows high RMSD values in WT cytochromes (35, 36).  208 
The heme iron coordination is insensitive to Tyr48 phosphorylation  209 
9 
We tested the effects of the mutation on the heme iron coordination environment and the 210 
axial coordination restraints used in our structure computations by using X-ray absorption 211 
spectroscopy (XAS), studying both WT and Y48pCMF species (Figure 2d and Figure 212 
S5c-f). The absorption spectra of the two proteins are almost identical. The X-ray 213 
absorption near-edge structure (XANES) region of the absorption spectra for both 214 
proteins are superimposed (Figure S5c). The absence of any shift in the energy position 215 
of the absorption edge indicates that the mutation did not affect the electron density at 216 
the Fe center.  217 
Likewise, the extracted extended X-ray absorption fine structure (EXAFS) signals of the 218 
WT and Y48pCMF Cc species were highly similar. However, small differences in high 219 
wave vector (k) values can be observed (Figure S5d), as well as in the slightly lower 220 
amplitude of the Y48pCMF protein. While the corresponding Fourier transforms are also 221 
very similar (Figure S5e), the amplitude of the first peak is lower and broader in the 222 
Y48pCMF Cc species, suggesting a larger degree of disorder. The dynamic disorder for 223 
the two proteins should be similar, as the measurements were performed at cryogenic 224 
temperatures in both cases. Hence, the differences in disorder are due to a larger static 225 
disorder in Y48pCMF Cc. The main scattering paths contributing to this peak originate 226 
from the four nitrogen atoms of the porphyrin ring, although contributions of the nitrogen 227 
and sulphur axial ligands have also been included. The fit to the data requires the 228 
addition of the paths involving the eight porphyrin carbons closest to the iron atom, 229 
beyond the first coordination sphere. In addition, the multiple scattering paths involving 230 
these atoms were also included. Fits were performed in R space but also reproduced 231 
well the spectra in q space (Figure S5f). The parameters obtained from the best fit to 232 
the data revealed that the distances between the iron atom and its first coordinating 233 
ligands are insensitive to the Y48pCMF mutation (Table S3). Specifically, the distances 234 
from the iron center to the axial S ligand are 2.26 ± 0.001 Å and 2.25 ± 0.001 Å in the 235 
WT and phosphomimetic mutant species, respectively (Figure 2d). Data analyses also 236 
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showed that the value for the Debye-Waller factor corresponding to the path involving 237 
the four porphyrin nitrogen atoms increased from 0.0012 ± 0.0006 Å2 in the WT species 238 
to 0.003 ± 0.001 in the Y48pCMF mutant. These data are consistent with the preserved 239 
chemical-shift pattern of the iron axial ligands and heme substituents observed in 1D 1H 240 
NMR (Figure 1d), which have been reported to be sensitive indicators of the heme iron 241 
electronic structures (35, 36). The pattern of the observed NOEs for the heme 242 
substituents also supports an overall intact heme pocket, with the exception of the 243 
mutation site. Still, the ensemble of structures shows a small change in the orientation 244 
of Phe82 with respect to the porphyrin ring (Figure S6). 245 
Phosphorylation of Tyr48 enhances internal mobility in cytochrome c 246 
NMR relaxation measurements were performed to evaluate the dynamics of WT and 247 
Y48pCMF Cc. The Y48pCMF substitution slightly affected both relaxation rate (R1 and 248 
R2) parameters (Table S4). The rotational correlation time of the phosphomimetic mutant 249 
(6.96 ± 0.02 ns) was higher than that of the WT form (6.33 ± 0.02 ns), in agreement with 250 
the small increase (pnul values of approximately 10–251) in the average gyration radius, 251 
from 12.95 ± 0.07 Å to 13.04 ± 0.06 Å, as calculated by MD. Indeed, phosphorylation 252 
can alter protein dynamics at different timescales and cause conformational 253 
rearrangements, such as the formation of secondary conformations (43, 44).  254 
Comparing R1, R2 and heteronuclear NOE (HetNOE) relaxation measurements recorded 255 
on the two proteins revealed that the ΩNY loop of Y48pCMF Cc exhibits a high mobility 256 
in the ps-ns time scale (Figure 3). Indeed, the Gly41–Lys55 segment showed a drastic 257 
drop of HetNOE values in the mutant species (Figure 3a). Further, the amide R1 rates 258 
for the sequence stretch of Tyr46–Lys55 in Y48pCMF Cc differ from those in WT Cc 259 
(Figure 3b). In addition, R2 analyses reveals three regions undergoing conformational 260 
exchange in the s-ms time scale: His26–Thr28, Thr40–Trp59 and Ile75–Thr78 (Figure 261 
3c). This behavior agrees with the reduced intensity or lack of detection of the amide 262 
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signals belonging to these stretches, as compared to the WT form. Furthermore, some 263 
regions within the protein displayed signals corresponding to double conformations in 264 
the 2D 1H NOESY spectra—namely, Val20–Asn31, Thr40–Trp59 and Ile75–Glu90, 265 
indicating the presence of conformational equilibria between two different structures 266 
occurring on a slow-time scale with respect to the NMR chemical shift. This dynamics 267 
involves residues located in a defined region surrounding the non-canonical amino acid 268 
(Figure 3d). Altogether, the NMR relaxation measurements of Y48pCMF Cc agree with 269 
the per-residue S2 order parameter values computed with TENSOR (45) (Figure 3e). 270 
Hydrogen-deuterium exchange experiments showed that a common core region is 271 
protected from solvent amide-hydrogen exchange in both Cc species. Nevertheless, a 272 
substantial number of amides become unprotected in pCMF48 Cc (Figure S7). The 273 
newly accessible amide protons in the phosphomimetic mutant (Gly29, Gly37, Arg38, 274 
Thr40, Gln42 and Trp59) are located in the surroundings of pCMF48 and the nearby ΩG 275 
loop, in agreement with their high mobility in the s-ms time scale.   276 
 277 
Tyr48 phosphorylation modulates the interaction of cytochrome c with its 278 
mitochondrial partners in the electron transfer chain  279 
Cc carries electrons from Cbc1 to CcO within the ETC. To elucidate more details about 280 
the process, we analyzed the molecular recognition between the soluble N-terminal 281 
domain of plant cytochrome c1 (Cc1) or bovine CcO with the phosphomimetic human 282 
Y48pCMF Cc. The human and plant N-terminal domains of Cc1 have a 62% overall 283 
sequence identity and similar charge distributions on their molecular surfaces (46), 284 
whereas the bovine and human CcO are evolutionarily-related proteins, with 91% and 285 
96% sequence identity and homology, respectively.  286 
Two binding sites for human and plant Cc on plant Cc1 have been recently reported (46, 287 
47). The proximal site is located near the heme moiety and is compatible with electron 288 
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transfer, while the distal site lies far from the heme group and probably constitutes a local 289 
energy minimum of the encounter ensemble.  290 
To test how Tyr48 phosphorylation affects the conformation of the Cc1-Cc complex, we 291 
recorded 1H-15N HSQC spectra upon titration of 15N-labeled reduced Cc with unlabeled 292 
reduced Cc1. Several amide signals exhibited significant chemical-shift perturbations 293 
(CSPs), thus indicating a fast exchange rate within the NMR time scale (Figure 4a,b). 294 
Average amide CSPs (Avg) were larger than 0.075 ppm for eleven residues: Gln16, 295 
Lys27, Gly29, Ala50, Lys55, Ile58, Lys72, Gly77, Met80, Ile81 and Val83 (Figure 4b). 296 
The fits of CSPs along the titration suggested that Cc1 binds two Y48pCMF Cc 297 
molecules, as previously found with the WT Cc species (46, 47) (Figure 4c). Using NMR 298 
spectroscopy, the dissociation constant (KD) values for the Cc1-Y48pCMF Cc complex 299 
were estimated to be 0.6 M and 102 M for the proximal and distal binding sites, 300 
respectively. All the perturbed residues, except Lys55 and Ile58, surround the heme 301 
crevice, as previously described for the interaction between WT Cc and Cc1 (46, 47) 302 
(Figure 4d). In fact, this region constitutes a very well-conserved interaction surface in 303 
c-type cytochromes (48-51). Lys55 and Ile58, in turn, are located in the ΩNY loop, which 304 
undergoes a conformational exchange in free Y48pCMF Cc (Figure 4d). In addition, 305 
significant CSPs (Avg ≥ 0.05 ppm) were detected for Lys7, Lys13, His26, Lys39, Ala43, 306 
Thr78, Lys86, Lys88 and Glu89. Interestingly, Lys8, Lys13, Lys27, Lys72 and Lys86 also 307 
experienced large CSPs, as previously reported for the interaction between WT Cc and 308 
Cc1 (46, 47).  309 
To obtain further data on the binding affinity and stoichiometry of the interaction between 310 
the two redox proteins, isothermal titration calorimetry (ITC) experiments were performed 311 
on both redox states. The isotherms obtained by titrating reduced Y48pCMF Cc with 312 
reduced Cc1 are displayed (Figure 4e, left panel). For the interaction between Cc and 313 
Cc1, the isotherm clearly shows two components with opposite signs in their respective 314 
enthalpy terms, thereby indicating the presence of two binding sites, in agreement with 315 
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the NMR data herein presented and previous reports on the WT species (46, 47). Indeed, 316 
all data fit a model with two independent binding sites in the corresponding Cc partner 317 
(Table S5). The interaction between Y48pCMF Cc and Cc1 was entropy-driven. At pH 318 
7.4, KD value at the proximal site was half that observed for WT Cc, whereas that at the 319 
distal site was four times higher (Table S5). This could be ascribed to the extra negative 320 
charge at position 48, which alters the surface electrostatic potential of the hemeprotein 321 
(Figure S8). Both Cc1–Y48pCMF Cc and Cc1-Cc complexes in their oxidized states 322 
showed similar thermodynamic and equilibrium parameters at both acidic and basic pH 323 
values. The only exception was the KD value for the oxidized Cc1–Y48pCMF Cc complex, 324 
at the proximal site of Cc1, that was approximately four times lower than that for the 325 
oxidized Cc1-WT Cc adduct at pH 8.5. ITC measurements of the oxidized Cc1–Y48pCMF 326 
Cc complex were not run at pH 7.4 because the pKa for the alkaline transition, which is 327 
specific to the ferric state (52), shifts to neutral pH upon Tyr48 phosphorylation (31). 328 
Hence, the WT and phosphomimic forms of oxidized Cc can differ in their sixth axial 329 
ligand at pH 7.4 (Table S5).  330 
In addition, we analyzed the binding affinity of the cross-complex between the reduced 331 
species of bovine CcO and human Y48pCMF Cc by ITC. The isotherm inflexion point 332 
lies at a 2:1 Y48pCMF-Cc:CcO ratio, thereby indicating the presence of two binding sites 333 
on CcO, as previously found for WT Cc (46, 53, 54). The best fit was achieved when the 334 
model used distinct KD values for the two independent binding sites (Figure S9). The 335 
resulting isotherms likewise fit to such model yielding different M-ranging KD values 336 
(Figure 4e, right panel, and Table S6) and enthalpy-driven interactions. Both the CcO 337 
proximal and distal sites had lower affinities for Y48pCMF Cc than the WT species, as 338 
previously reported (46) (Table S6). Altogether, these data agree with previous steady 339 
state kinetic analysis that demonstrated a binding model with more than one molecule of 340 
Cc per molecule of Cbc1 (55) and with kinetic-based models that proposed the existence 341 
of alternative, non-productive binding sites for horse Cc in bovine CcO (54). In addition, 342 
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direct binding studies performed by gel filtration between several mammalian Cc and 343 
bovine CcO evidenced a 2:1 stoichiometry, in which Cc bound to a first site with a 344 
dissociation constant within the nM range and to a second site with less affinity (53).  345 
To assess the functional ability of Y48pCMF Cc to reduce respiratory complex IV, we 346 
tested the CcO activity of isolated complex IV or Cc-free mitochondria (ΔCc) from yeast 347 
cells grown with glucose as a carbon source (Figures 5a and S10a). In both cases, the 348 
Cc oxidation rate was at least two-fold higher with Y48pCMF Cc than with WT Cc, 349 
thereby suggesting that Tyr48 phosphorylation enhances the ability of Cc to donate 350 
electrons to complex IV. Direct measurements of O2 consumption were consistent with 351 
such data (Figure S10b). Interestingly, the CcO activity was positively regulated by the 352 
human membrane proteins hypoxia-inducible domain family members 1A and 2A 353 
(HIGD1A and HIGD2A), which promote cell survival under hypoxia. HIGD2A was 354 
successfully expressed in cell-free expression systems combined with n-dodecyl--D-355 
maltoside, as previously reported for HIGD1A (56) (Figure S11a-c). HIGD1A 356 
significantly increased the rate of CcO-catalyzed oxidation of Y48pCMF Cc (Figure 5b), 357 
as reported for WT Cc (57). Strikingly, HIGD2A induced an even a stronger positive effect 358 
than HIGD1A (Figure 5b). Nevertheless, the HIGD-dependent increase in CcO activity 359 
was slightly lower with Y48pCMF Cc (Figure 5b). This may be due to HIGD-dependent 360 
changes in either the complex IV affinity towards Cc or in the restraints of Cc diffusion 361 
(channeling) from Cc1 to complex IV. A direct Cc-HIGD interaction can also not be 362 
excluded. 363 
To confirm the HIGD-mediated regulation of the CcO activity in a cellular context, we 364 
isolated mitochondria from different yeast strains grown either with glucose (YPD 365 
medium), which supports fermentation and respiration, or with the non-fermentable 366 
carbon sources lactate and galactose (YP-Gal) (58). Under both metabolic conditions, 367 
the isoformic respiratory supercomplex factors 1 (Rcf1, formerly Aim31) and 2 (Rcf2, 368 
formerly Aim38) are constitutively expressed (Figure 5c, inset), in agreement with their 369 
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role in CcO activity and supercomplex stability (58-60). Rcf1 is a yeast orthologue of the 370 
human HIGD1A and HIGD2A proteins, whereas Rcf2 is specific to yeast. The external 371 
membranes of isolated mitochondria were then permeabilized to allow the entry of 372 
exogenous WT or Y48pCMF Cc. Under these conditions, mitochondria isolated from a 373 
yeast strain deficient of both Rcf1 and Rcf2 (Rcf1/2), as verified by western blot, 374 
displayed an endogenous CcO activity lower than those isolated from WT yeast (WTRcf), 375 
no matter which type of exogenous hemeprotein—WT or Y48pCMF Cc—was used for 376 
supplementing (Figure 5c). This indicates that Rcf1 and Rcf2 act as positive modulators 377 
of CcO activity, similar to human HIGD proteins. In mitochondria isolated from yeast 378 
grown with non-fermentable carbon sources, the Rcf-mediated increase in CcO activity 379 
was less prominent when Y48pCMF Cc rather than WT Cc was added as an exogenous 380 
electron donor, in agreement with the in vitro behavior of isolated proteins (Figure 5b). 381 
This suggests that Tyr48 phosphorylation makes Cc less sensitive to the enhancer 382 
mechanism of the Rcf proteins and/or to the ability of Rcfs to stabilize the Cbc1-CcO 383 
supercomplexes (Figure 5c). In fact, Rcf1 and Rcf2 promote the supercomplex 384 
assembly, preferably in mitochondria from yeasts grown in a respiratory-based medium 385 
(Figure 5d and Figure S11d). This is especially remarkable when comparing the band 386 
intensities in an anti–COX-2 immunoblot (Figure 5d). Note that such OxPhos 387 
supercomplexes could show a certain degree of heterogeneity in their composition, since 388 
the gene transcription of COX5a and COX5b—which encode for two CcO isoforms—are 389 
repressed and active, respectively, in the aerobic-to-anaerobic metabolic transition (61). 390 
Moreover, the faint band pattern of Rcf1/2 strains grown in YPD medium in the BN-391 
PAGE corresponds to supercomplexes, thus suggesting that other factors may 392 
contribute to their assembly (Figure 5d and Figure S11d). 393 
Altogether, our data suggest that phosphorylation of Cc at Tyr48 modulates the 394 
mitochondrial ETC (Figure 5e). Such a posttranslational modification allows a fast 395 
adaptation of the hemeprotein function to changing cell conditions. The population of 396 
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Cbc1-CcO supercomplexes is less prominent in the presence than in the absence of 397 
glucose, although Rcf proteins are still expressed. In any case, Cc channeling from Cbc1 398 
towards CcO is impaired. At a physiological pH, Tyr48 phosphorylation thus favors 399 
binding of Cc to the proximal rather than to the distal site of Cc1. Under respiration-based 400 
growth, the Rcf proteins preferably associate directly with the OxPhos supercomplex, 401 
bridging Cbc1 and CcO. However, the weaker Y48pCMF Cc-CcO binding, along with the 402 
loss of the distal site on Cc1 due to phosphorylated Cc, impairs the channeling of Cc 403 
molecules that functionally connects Cbc1 with CcO, which has been proposed to occur 404 
with WT Cc (46, 47). As a consequence, Y48pCMF Cc is less efficient than WT Cc as 405 
an electron carrier towards CcO in the context of OxPhos supercomplexes.  406 
 407 
Tyr48-phosphorylated cytochrome c acts as an improved peroxidase-like enzyme, 408 
in particular when bound to cardiolipin-containing liposomes 409 
Assembly of the mitochondrial protein membrane complexes Cbc1 and CcO into OxPhos 410 
supercomplexes enables more efficient electron flow and decreases ROS levels 411 
generated by the ETC (62). The phospholipid CL, located in the inner mitochondrial 412 
membrane, also stabilizes the resulting supercomplexes (63) in a HIGD/Rcf-independent 413 
manner (58). In addition, CL interacts with Cc in a two-step binding reaction (64): in the 414 
first step, the so-called A-site at the Cc surface makes transient electrostatic contacts 415 
with the membrane; in the second step, hydrophobic forces drive the formation of a tight 416 
and stable Cc-CL complex, with one of the CL acyl chains entering the hydrophobic 417 
groove of Cc (termed the C-site) (65-67). C-site binding then triggers Cc-regulated CL 418 
peroxidation under oxidative stress and induces early apoptosis (39). Interestingly, 419 
several residues of Cc (Lys22, Lys27 and His33) become protonated at low pH to form 420 
an extra binding site – the so-called L-site – that facilitates the electrostatic interaction of 421 
Cc with mitochondrial membranes (68). 422 
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Within this frame, we analyzed how tyrosine phosphorylation can fine-tune the affinity of 423 
Cc towards CL-containing liposomes, analyzing binding of Cc species to liposomes in 424 
HEPES buffer at a physiological pH value by electrophoretic mobility shift assays 425 
(EMSA) in native agarose gels (Figure 6a,b). To compare the binding properties of Cc 426 
species to the CL-containing liposomes of 4:1 DOPC:TOCL (1,2-dioleoyl-sn-glycero-3-427 
phosphocholine:1,1’2,2’-tetraoleoylcardiolipin) or to the liposome DOPC alone, we 428 
measured the mobility profiles of Cc at different Cc:lipid ratios. While both WT and 429 
Y48pCMF Cc bound to DOPC:TOCL and DOPC vesicles, their binding affinity for the 430 
CL-free DOPC liposomes seemed to be lower (Figure 6a,b). Notably, the presence of 431 
free hemeprotein at high lipid concentrations suggested that Y48pCMF Cc has a lower 432 
affinity than WT towards DOPC:TOCL liposomes (Figure 6b), as recently observed for 433 
the phosphomimetic mutant S47D Cc (69). Another interesting finding is the unspecific 434 
interaction of Cc —either the WT or Y48pCMF species—with DOPC vesicles (Figure 435 
6a,b).  436 
ITC measurements corroborated these EMSA data. ITC experiments were performed 437 
under aerobiosis to mimic physiological conditions, despite using degassed samples. 438 
This may result in partial oxidation of Cc upon binding to liposomes, as previously 439 
reported (70). ITC analysis yielded the apparent KD values for the first binding event of 440 
427 M (WT Cc) and 780 M (Y48pCMF Cc) (Figure 6c). Data for the interaction of WT 441 
Cc with liposomes are consistent with the KD values reported before (67, 71, 72, 73), but 442 
they diverge from the lower KD values reported in the literature (74) and the A/C two-site 443 
binding model described by Kinnunen and co-workers (65, 66). Such discrepancies are 444 
still unresolved and further research is necessary to harmonize data from all these 445 
different binding assays in a unified and single model. The interaction with CL resulted 446 
in apparent H values equal to 2.75 kcal mol–1 for WT Cc and 38.97 kcal mol–1 for 447 
Y48pCMF Cc. The differences in KD indicate a small change in binding energies (of 448 
approximately 6 kcal mol–1). Hence, the changes in H are indicative of enthalpy-entropy 449 
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compensation effects, which are compatible with the electrostatic change resulting from 450 
the extra carboxylate group of the Y48pCMF species. Further, an exothermic process 451 
can be observed, with longer peak equilibrium times upon successive lipid additions. In 452 
this case, the apparent ΔH values with the WT and Y48pCMF Cc species were equal to 453 
–6.97 kcal mol–1 and –47.84 kcal mol–1, respectively, but the apparent KD value (of 454 
approximately 1 mM) was practically the same with the two Cc species. Altogether, our 455 
EMSA and ITC assays indicate that Y48pCMF Cc binds to CL-containing liposomes with 456 
a slightly lower affinity than WT Cc.  457 
WT Cc undergoes CL-dependent conformational changes that allow H2O2 to access the 458 
heme crevice (73). Hence, we addressed whether the affinity differences between WT 459 
and Y48pCMF Cc for CL could affect their peroxidase activity. In the absence of CL-460 
containing liposomes, Y48pCMF Cc exhibited a three-fold higher peroxidase activity than 461 
WT Cc (Figure 6d). However, the presence of TOCL/DOPC vesicles, at a 1:100 Cc:lipid 462 
ratio, increased the enzymatic activity of both WT and Y48pCMF Cc, similar to that 463 
observed for other phosphomimetic Cc mutants (69). Note that the slightly lower 464 
peroxidase activity increment observed for Y48pCMF Cc is likely due to its higher 465 
population of free protein as compared to WT Cc (Figure 6b,d).  466 
 467 
Tyr48 phosphorylation is an anti-apoptotic posttranslational modification 468 
Phosphorylated Cc may be more easily released from mitochondria because of its lower 469 
affinity towards CL, as inferred from EMSA and ITC assays. Translocation to the cytosol 470 
could thus enable phosphorylated Cc to interact with Apaf-1 and to assemble the 471 
caspase-activating apoptosome. However, cytosolic caspase-3 activation was 472 
decreased by about 60% in the presence of the Y48pCMF Cc mutant (Figure 6e). This 473 
is in agreement with the behavior previously reported for the Y48E Cc mutant, which 474 
exhibits a lower ability than WT Cc to activate not only caspase-3 (26) but also 475 
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procaspase-9 by non-functional apoptosome assembly (27). These results could thus be 476 




Here we tackle the structural and functional characterization of the Y48pCMF variant of 481 
human Cc. This mutation mimics protein phosphorylation at Tyr48 by adding a negative 482 
charge and slightly increasing the side-chain size while keeping the aromatic ring. A 483 
recent spectroscopic analysis of Y48pCMF Cc showed a singular shift of the typical 484 
alkaline transition pKa to physiological pH values (31), as is the case with the Y48E Cc 485 
mutant (26, 27). Here, we report NMR-based structure computations that indicate that 486 
Tyr48 phosphorylation maintains the core foldon of Cc but increases internal motions in 487 
the loops ΩNY, ΩR and ΩG. Specifically, the ΩNY loop, the most unstable folding unit of the 488 
hemeprotein, becomes looser and reaches conformational equilibria in Y48pCMF Cc. 489 
Enhanced motions at the ΩG and ΩR loops could be associated to the shift in the alkaline 490 
transition pKa. Indeed, these two loops hold the residues that provide the iron axial 491 
ligands, which are observed to at least partially lose their metal coordination in the 492 
alkaline form (75). This is in contrast to XAS data that suggest that axial coordination 493 
remains untouched. However, the cryogenic temperatures at which the XAS spectra 494 
were recorded may amplify the most stable structures and reduce contributions from 495 
minority species with a high disorder, which are undetectable. 496 
The local but substantial changes in conformation and dynamics of the regions 497 
surrounding the Y48pCMF mutation increased the solvent accessibility of the porphyrin 498 
ring, thereby enhancing cytochrome peroxidase activity. Thus, Y48pCMF Cc proficiently 499 
scavenges ROS and avoids damage of cellular components (Figure 7). Our findings 500 
also indicate that Y48pCMF Cc binds to mitochondrial CL with a lower affinity than WT 501 
Cc but Y48pCMF Cc shows a higher peroxidase activity upon binding to liposomes. 502 
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According to the literature, both events may facilitate Cc translocation to the cytoplasm 503 
during apoptosis (76). However, phosphorylation at Tyr48 hinders the proapoptotic 504 
activity of extramitochondrial Cc, similar to the function of HIGD1A protein in ischemia 505 
and tumorigenesis (77). Indeed, both HIGD1A and Y48pCMF Cc act as pro-survival 506 
proteins by preventing apoptotic caspase activation (Figure 7) (78).  507 
As expected, the Y48pCMF mutation affects the binding mode of Cc to its well-known 508 
respiratory partners Cbc1 and CcO. Not surprisingly, the enhanced internal motions of 509 
the loops ΩNY and ΩR and the electrostatic change at the interaction patch resulting from 510 
the additional carboxyl group affect the interaction of Y48pCMF Cc with the two 511 
membrane complexes. The mutation-induced changes in electrostatics and in solvation 512 
at the interface also concur for the interaction of reduced Y48pCMF Cc with the distal 513 
sites of CcO (and Cc1), as inferred from the high decrease in the dissociation enthalpies 514 
and the strong (or moderate) enthalpy-entropy compensation herein reported. Indeed, 515 
the binding of Y48pCMF Cc on the Cc1 surface is weak and functionally irrelevant at the 516 
distal site but is favored at the proximal site (Figure 5e). When the turnover of the redox 517 
carrier at the main site is considered, the high affinity of reduced Y48pCMF Cc inhibits 518 
its own replacement by oxidized Cc molecules, thereby impairing the electron transport.  519 
The Cc:CcO complex keeps its interface solvated, according to the recent X-ray 520 
diffraction structure (79), which displays  a protruding lysine sidechain in CcO pointing to 521 
Tyr48 in Cc. A salt bridge involving phosphorylated Tyr48 would restrain the NY loop. 522 
The increase in the dissociation constant (KD) of the complex between Y48pCMF Cc and 523 
CcO (this work) and the decrease in the Michaelis constant (KM) of phosphorylated Cc 524 
with CcO (80) indicate that KM is mainly governed by the catalytic step. This agrees with 525 
the larger CcO-driven oxidation rate of Y48pCMF Cc compared with that of WT Cc at the 526 
limiting protein concentrations in the enzymatic activity assays used here. In this context, 527 
the ca. 60 mV decrease in the E0 of Y48pCMF Cc (31) may facilitate the electron flow 528 
from Cc to CcO although it may impair Cc reduction by Cbc1. In other words, Y48pCMF 529 
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Cc exhibits a reduced ability as oxidizing agent (it is less capable than WT Cc to receive 530 
electrons from Cc1), but displays an increased capacity as reducing agent (it is a better 531 
electron donor to CcO than WT Cc). It is well known that the catalytic step can be tuned 532 
by conformational changes of Cc upon binding to CcO (51). Strikingly, these changes 533 
resemble the prominent internal dynamics of Y48pCMF Cc, which could also explain not 534 
only the change in E0, but also the shift in the alkaline transition pKa of oxidized Y48pCMF 535 
Cc (31). Therefore, the transition from reduced to oxidized Y48pCMF Cc, which is 536 
accompanied by a change in the iron axial ligand at physiological pH, is expected to have 537 
a high-energy barrier (81). Hence, such conformational changes might be the limiting 538 
step for Y48pCMF Cc oxidation inside the complex.  539 
Under nutrient and oxygen depletion, a dysfunctional mitochondrial ETC and OxPhos 540 
can lead to many human diseases, including pathologies like ischemia and cancer (24). 541 
The nexus in both disorders could be the control of mitochondrial ET rate by Cc 542 
phosphorylation (23), which has indeed been reported to efficiently fine-tune respiratory 543 
rates (80). Even though HIGD-mediated assembly of Cbc1 and CcO into OxPhos 544 
supercomplexes preferably occurs under low glucose conditions, the decrease in both 545 
the CcO activity and the binding affinity towards Cc1 and CcO resulting from the 546 
enhanced dynamics of Y48pCMF Cc could explain the disruption of Cc channeling inside 547 
the Cbc1-CcO supercomplex, thus slowing down the ETC flow (Figure 7).  548 
Intriguingly, not only respiratory supercomplex formation (59, 60)–whose structure has 549 
been recently solved (82, 83)–but also Cc phosphorylation, and the resulting decrease 550 
in the ETC rate, could help to keep ROS levels low and to guarantee cell survival.  551 
Tyr48-phosphorylated Cc could be targeted as a biomarker of mitochondrial dysfunction 552 
with associated pathological states, such as ischemia/reperfusion and cancer. 553 
Deciphering the details of the phosphorylated Cc–controlled complex network requires 554 
accurate structural and dynamic analyses, to eventually develop robust therapeutic 555 
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approaches to foster or silence—as required—the pro-survival action of phosphorylated 556 
Cc reported here.  557 
 558 
 559 
MATERIAL AND METHODS 560 
Methods and any associated references are available in the Supplementary Information. 561 
Accession codes. NMR assignments and PDB coordinates for the Y48pCMF Cc were 562 
deposited in the Biological Magnetic Resonance Data Bank (BMRB; entry 25660) and 563 
PDB (2N3Y code) databases.  564 
All biological samples were obtained from bacteria, yeasts or human cell extracts, in fully 565 
compliance with the University of Seville Ethical Committee bylaws. 566 
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FIGURE LEGENDS 803 
Figure 1. Control of human cell fate by Cc-based signalosome, and 804 
biophysical and structural characterization of the Y48pCMF variant of Cc. (a) 805 
Diagram of the role of Cc in homeostasis and apoptosis. Left, Under homeostatic 806 
conditions, Cc (red circles) transfers electrons from cytochrome bc1 complex (Cbc1) 807 
to cytochrome c oxidase complex (CcO). Right, Upon apoptotic stimuli, Cc is 808 
released to the cytosol to induce apoptosome formation and block pro-survival 809 
pathways. A portion of Cc remains bound to cardiolipin (CL). (b) Far-UV CD spectra 810 
of the reduced forms of WT (blue) and Y48pCMF Cc (red). The same color-code is 811 
maintained in the following panels. (c) Superimposition of the 1H–15N HSQC spectra 812 
of uniformly 15N-labeled forms of WT and Y48pCMF Cc. Backbone amide 813 
resonances of Y48pCMF Cc are labelled in red and black. Particular amide 814 
resonances of WT Cc are labelled in blue. (d) Detailed view of the 1H NMR spectra 815 
of WT and Y48pCMF Cc at negative ppm values. Resonances for Met80 side-chain 816 
protons are shown for both Cc species. Assigned signals of all residues within this 817 
region are displayed for Y48pCMF Cc. The extra signal of WT Cc corresponds to 818 
the Qδ1 protons of Ile53. (e) Superimposition of the aromatic region of the 1H–13C 819 
HSQC spectra of WT and Y48pCMF Cc acquired in 13C natural abundance. 820 
Assigned aromatic resonances of Y48pCMF Cc are displayed in red. 821 
 822 
Figure 2. NMR solution structure of the Y48pCMF variant of Cc. (a) Stereo-view 823 
ribbon representation of the 20 best conformers of Y48pCMF Cc. Heme group atoms 824 
are displayed for all conformers. Ribbons are colored in red, whereas atoms from 825 
the heme group are colored following the CPK color scheme. Foldons of Y48pCMF 826 
Cc are shadowed and marked with Roman numerals, except for foldon III, which is 827 
located behind foldon IV. (b) Comparison between the NMR solution structures of 828 
WT Cc (PDB ID: 1J3S) (33) and Y48pCMF Cc (this work). The ribbon for WT Cc is 829 
in blue. The five α-helices of both Cc species, as well as the mutation-containing 830 
33 
loop of Y48pCMF Cc, are marked. Arrows point to the regions on the Y48pCMF Cc 831 
ribbon with substantial structural changes as compared to the WT form. (c) Detailed 832 
view of the loop harboring the pCMF48 residue. pCMF48 atoms follow the CPK color 833 
scheme. Protein structures were represented with the UCSF Chimera software (40). 834 
(d) Detail of the heme group and axial ligands. Labels display iron-to-axial ligand 835 
distances for the Y48pCMF mutant obtained from the EXAFS analysis (see Figure 836 
S5).  837 
 838 
Figure 3. Relaxation NMR measurements and dynamic properties of WT and 839 
Y48pCMF Cc. (a–c) Differences in Heteronuclear NOE (a), relaxation rate R1 (b) 840 
and relaxation rate R2 (c) between the experimental values for the reduced forms of 841 
WT and Y48pCMF Cc, plotted as a function of the residue number. Gaps in data 842 
result from overlapping resonances, broadened resonances beyond the detection 843 
limit and unassigned resonances. A scheme of the secondary structure elements is 844 
included at the top of each plot. (d) Map of the Y48pCMF Cc residues colored 845 
according to their dynamic properties. Affected residues in the heteronuclear NOE 846 
and relaxation rate R2 parameters are colored in yellow and orange, respectively. 847 
Residues with backbone amide resonances that are undetectable in the 1H–15N 848 
HSQC spectrum of Y48pCMF Cc but detectable in the 1H–15N HSQC spectrum of 849 
WT Cc are colored in red. pCMF48 is shown in black and the heme group, in green. 850 
Unaffected, unassigned and proline residues are in blue. (e) Internal mobility 851 
comparison between Y48pCMF and WT Cc. S2 order parameter values per residue 852 
for Y48pCMF (upper) and WT (lower) Cc are represented on the respective NMR 853 
ribbon structures using a blue-red scale. Undetectable backbone resonances are in 854 
gray. Heme atoms are in green with the axial ligands depicted in sticks.  855 
 856 
Figure 4. Binding assays between Y48pCMF Cc and its respiratory partners. 857 
(a) Overlay of selected residues of 1H–15N HSQC spectra of 15N-labeled Y48pCMF 858 
34 
Cc along with titration with Cc1. Signals corresponding to different titration steps are 859 
colored according to the code indicated in the panel. (b) Plot of chemical-shift 860 
perturbations (CSPs) of 15N-labeled Y48pCMF Cc as a function of residue number. 861 
Proline and non-assigned residues are marked by asterisks. Color bars stand for the 862 
Δδavg categories, as follows: insignificant Δδavg < 0.025 ppm, blue; small 0.025 ≤ 863 
Δδavg < 0.050 ppm, yellow; medium 0.050 ≤ Δδavg < 0.075 ppm, orange; and large ≥ 864 
0.075 ppm, red. (c) Upper, curves representing the best global fit of several amide 865 
signals in 1H dimension to a 2:1 ratio for the Y48pCMF Cc-Cc1 binding model with 866 
two different global KD values. Lower, binding curves of Gln16. Lines represent the 867 
best fit to 1:1 (red) and 2:1 (black) binding models. (d) CSP map of reduced 868 
Y48pCMF Cc upon addition of reduced Cc1 at a 1:1 ratio. Residues are colored 869 
according to the Δδavg categories, as indicated in (b). Proline and non-assigned 870 
residues are in gray. (e) ITC measurements of the Y48pCMF Cc-Cc1 and Y48pCMF 871 
Cc-CcO complexes in their reduced states. Experimental data were fitted to a 2:1 872 
binding model. Thermograms are shown in the upper panels, and binding isotherms, 873 
in the lower panels. 874 
 875 
Figure 5. CcO activity with WT or Y48pCMF Cc as the electron donor. (a) CcO 876 
activity of isolated complex IV and of mitochondria lacking Cc (ΔCc) upon addition 877 
of exogenous WT (blue bars) or Y48pCMF Cc (red bars). Western blot results 878 
confirmed the lack of endogenous Cc in ΔCc mitochondria (see inset). (b) In vitro 879 
modulation of CcO activity by HIGD1A and HIGD2A. WT Cc (blue bars) or Y48pCMF 880 
Cc (red bars), along with HIGD1A or HIGD2A at the indicated ratios, were added to 881 
isolated complex IV. (c) Effect of the modulators Rcf1 and Rcf2 on the CcO activity 882 
of mitochondria isolated from yeasts grown in YPD or YP-Gal media with either WT 883 
Cc (blue bars) or Y48pCMF Cc (red bars). All data represent the mean ± SD of three 884 
independent experiments. In all cases, CcO activity was detected only upon addition 885 
of exogenous Cc but not with endogenous Cc. Inset, Western blots of WTRcf 886 
35 
mitochondria (lane 1) and mitochondria lacking Rcf1 and Rcf2 (ΔRcf1/2) (lane 2). 887 
(d) Blue-native gel (BN-PAGE) and Western blots of mitochondria from WTRcf and 888 
ΔRcf1/2 strains, using antibodies against Rcf2 and COX-II. Bands submitted to 889 
tryptic digestion (Figure S11d) are highlighted by asterisks. (e) Scheme of the 890 
interactions within the electron transport chain involving Ccb1, CcO, Rcf proteins and 891 
WT or Y48pCMF Cc, as a function of glucose (Glu) availability. The Rcf proteins 892 
facilitate the interaction between Ccb1 and CcO to form OxPhos supercomplexes, 893 
mainly under glucose deprivation (right). Thickness of solid arrows refers to the 894 
electron transfer rate at the Cc-binding proximal sites of Cbc1 and CcO by WT or 895 
Y48pCMF Cc—the longer and thicker the arrow, the more efficient the electron 896 
transfer. Dashed line highlights the channeling of WT Cc molecules. 897 
 898 
Figure 6. Liposome-binding assays with caspase-3 activity induced by WT and 899 
Y48pCMF Cc. (a,b) Electrophoretic mobility shift assay (EMSA) of Cc in the 900 
presence of increasing concentrations of lipids. DOPC:TOCL (4:1) or DOPC 901 
liposomes were incubated with WT (a) or Y48pCMF (b) Cc. Note that free Cc 902 
species moved to the cathode, whereas liposome-bound Cc migrated to the anode. 903 
Lanes marked by rectangles correspond to the Cc:lipid ratio at which the peroxidase 904 
activity was determined (see below). (c) Calorimetric assays for lipid binding to Cc. 905 
Upper, ITC thermograms, corresponding to titrations of DOPC:TOCL 4:1 liposomes 906 
(black), WT Cc (blue) or Y48pCMF Cc (red). Lower, binding isotherms with WT Cc 907 
(blue dots) or Y48pCMF Cc (red dots). Continuous lines represent the best fits to a 908 
sequential binding, as computed with the Nanoanalyze software (TA instruments) 909 
with a stoichiometry of 30 molecules of lipid per molecule of Cc. (d) Relative 910 
peroxidase activities of WT Cc (blue) or Y48pCMF Cc (red) in the presence of 911 
liposomes containing DOPC (empty bars) or DOPC:TOCL (4:1) 901 (filled bars). (e) 912 
Relative caspase-3 activity in HEK293 cell extracts devoid of endogenous Cc upon 913 
addition of exogenous WT Cc (blue) or Y48pCMF Cc (red). A lack of caspase auto-914 
36 
activation was verified in a run without the addition of Cc (gray). Western blots 915 
confirmed the lack of endogenous Cc in cytoplasmic cell extracts after 916 
immunoblotting with anti α-tubulin (cytosolic marker) and anti-Cc antibodies (see 917 
inset). Lane 1, cytoplasmic cell extracts; lane 2, Cc; lane 3, BSA as a negative 918 
control. 919 
 920 
Figure 7. Schematic diagram illustrating the changes induced in cell function 921 
by phosphomimic Y48pCMF Cc. The negative charge at position 48 decreases 922 
CcO activity by disrupting Cc channeling in OxPhos supercomplexes (left), 923 
enhances ROS scavenger activity by increasing the peroxidase activity of CL-bound 924 
Cc (middle) and promotes the anti-apoptotic function of Y48pCMF Cc by inhibiting 925 
its ability to activate the caspase-3 cascade (right). 926 
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SUPPLEMENTARY METHODS 
Protein expression and purification 
Uniformly 13C,15N-labeled, 15N-labeled and unlabeled samples of the Y48pCMF variant 
species of cytochrome c (Cc)—in which tyrosine 48 was replaced by p-carboxymethyl-L-
phenylalanine (pCMF)—were expressed using the evolved tRNA synthetase technique and 
purified as previously described (1, 2). For isotopic labelling, 15N-labeled ammonium chloride 
and 13C-labeled glucose were added to minimal cell culture media to express the 13C,15N-
labeled protein samples, whereas only 15N-labeled ammonium chloride was added to media 
for 15N-labeled protein samples. Unlabeled pCMF and -aminolevulinic acid were added to 
a final concentration of 1 mM each after cell culture induction. Cultures were induced with 
IPTG and arabinose at 1 mM and 0.02% final concentrations, respectively. Tryptic digestion 
and MALDI-TOF analyses confirmed the molecular mass and the substitution of tyrosine by 
pCMF. Uniformly 15N-labeled and unlabeled samples of wild-type (WT) Cc were expressed 
and purified as reported previously (3). Protein concentration was determined by visible 
spectrophotometry, using an extinction coefficient of 29 mM–1 cm–1 for reduced Y48pCMF 
and WT Cc. For NMR experiments, pure Cc samples were first dialyzed against 10 mM 
sodium phosphate (pH 6.3), and afterwards concentrated in Millipore 3 K Nominal Molecular 
Weight Limit (NMWL) centricons until a final Cc concentration of 0.7 mM.  
Plant cytochrome c1 (Cc1) was obtained as described (4). Bovine cytochrome c oxidase 
(CcO) was purchased from Sigma; before use, the buffer was exchanged to 10 mM sodium 
phosphate buffer (pH 7.4), supplemented with 0.2% (w/v) n-dodecyl--D-maltoside (DDM) 
and 5 mM sodium dithionite, using Millipore 3K NMWL centricons, as reported previously 
(3). 
Hypoxia-inducible domain family members 1A and 2A (HIGD1A and HIGD2A, respectively) 
were expressed by cell-free protein synthesis using a continuous exchange reaction 
3 
(dialysis mode; ratio 1:10), with a 6 mL final volume. Briefly, 10 g mL–1 of either HIGD1A or 
HIGD2A-coding DNA in the pIVEX2.4d plasmid were added to the reaction mixture, which 
consisted of 1 mM amino acid mix, 0.8 mM ribonucleotides (guanosine-, uracyl- and cytidine- 
triphosphate), 1.2 mM adenosine triphosphate, 55 mM HEPES buffer (pH 7.5), 68 M folinic 
acid, 0.64 mM cyclic adenosinemonophosphate, 3.4 mM dithiothreitol, 27.5 mM ammonium 
acetate, 2 mM spermidine, 80 mM creatine phosphate, 208 mM potassium glutamate, 16 
mM magnesium acetate, 250 g mL–1 of creatine kinase, 27 g mL–1 of T7 RNA polymerase, 
0.175 g mL–1 of tRNA and 0.4 mL of S30 Escherichia coli (E. coli) bacterial extract. DDM 
detergent was added to a final concentration of 0.4% (w/v). For the feeding mix in the 
external tank (60 mL), the same conditions were used but omitting DNA, creatine kinase, T7 
RNA polymerase, tRNA and S30 E. coli bacterial extract. Incubation was carried out at 23°C 
with agitation for 16 h. The His-tagged forms of HIGD1A and HIGD2A were then purified by 
nickel affinity chromatography. The final yield was 125 g of protein per mL of reaction in 
both cases. Before using the HIGD proteins, the buffers were exchanged to 10 mM sodium 
phosphate buffer (pH 7.4) with 0.2% (w/v) DDM. 
 
Circular dichroism 
Circular dichroism (CD) spectra were recorded on a JASCO J-815 spectropolarimeter, 
equipped with a Peltier temperature system, in a 1-mm quartz cuvette. CD intensities were 
presented in terms of molar ellipticity [molar], based on molar protein concentration (5). 
Secondary structural elements of reduced WT and Y48pCMF Cc were analyzed by 
recording their respective far-UV CD spectra (185–250 nm) at 25°C. The samples contained 
3 M hemeprotein in 5 mm sodium phosphate buffer (pH 6.3), supplemented with 10 mM 
ascorbic acid. Twenty scans were averaged and analyzed for each sample, using the CDPro 
4 
software package (6, 7) SMP50 and SP37A were used as reference sets. CLSTR option 
was employed for comparison with a set of proteins with similar folds. 
 
Nuclear magnetic resonance experiments 
Nuclear magnetic resonance (NMR) spectra of fresh 0.6 mM reduced 13C,15N-labeled 
Y48pCMF Cc samples, in 90% buffer and 10% D2O, were recorded at 25 °C on Bruker 
Avance spectrometers operating at 950, 700 and 500 MHz 1H frequencies. A standard set 
of triple-resonance experiments, necessary for the full assignment of backbone and side-
chain resonances, were acquired at 700 MHz 1H frequency, whereas 2D and 3D NOESY 
experiments required for structure determination were acquired at 950 MHz 1H frequency. 
Recorded NMR experiments for determination of backbone resonances were 2D 1H-15N 
heteronuclear single-quantum correlation (HSQC), 2D 1H-13C HSQC, 3D HNCA, 3D 
HNCACB, 3D CACB(CO)NH, 3D HN(CA)CO and 3D HNCO, and specific experiments for 
determination of side-chain resonances were 3D HCCHTOCSY and 3D HBHA(CO)NH (8-
10). Additional 2D COSY and aromatic 2D 1H-13C HSQC spectra of an unlabeled sample of 
Y48pCMF Cc were acquired for the assignment of aromatic residues. Therefore, the 1H-13C 
HSQC spectrum was recorded in natural abundance of 13C. Water suppression was 
achieved in all mentioned spectra by WATERGATE (11) 1D 1H spectra were launched 
before and after each spectrum to check the state of the sample, and especially the redox 
state of the hemeprotein. 
The following NOESY experiments were acquired: 2D 1H-15N NOESY, 3D 1H-15N NOESY-
HSQC and 3D 1H-13C NOESY-HSQC spectra in the aliphatic region (12-14). Mixing times 
were 100 ms for all NOESY experiments, recorded on a 15N-labeled sample, with the 
exception of the 3D 1H-13C NOESY-HSQC, which was acquired on a 13C,15N-labeled sample. 
An additional 2D 1H-15N EXSY spectrum was launched for assignment of heme resonances 
5 
using a partially oxidized 15N-labeled sample. WATERGATE suppression was used. 1D 1H 
spectra were again launched to check the state of the samples.  
15N relaxation R1 (=1/T1), R2 (=1/T2) and {1H}-15N NOE parameters (also known as HetNOE) 
were obtained from standard experiments recorded at 500 MHz 1H frequency and 25 °C (15) 
on 15N-labeled samples of the Y48pCMF and WT Cc species. R1 and R2 values were 
obtained using 10 delays, of 1, 2.5, 10, 35, 70, 200, 380, 550, 740 and 3000 ms for R1 
experiments, and 16.96, 33.92, 67.84, 101.76, 135.68, 186.56, 237.44, 271.36, 305.28 and 
356.16 ms for R2 experiments. To determine HetNOE values, spectra were recorded in the 
presence or absence of a proton presaturation period. HetNOE, R1 and R2 values from 
residues in well-defined regions were used to estimate the comprehensive 15N relaxation 
parameters (16, 17). The R1/R2 ratio was used to estimate the rotational correlation time (c) 
of the protein constructs using TENSOR2 software (17). Internal mobility was also calculated 
by an isotropic model-free analysis via TENSOR2 routines (17). Amide hydrogen exchange 
experiments were also carried out on these 15N-labeled samples of the Y48pCMF and WT 
Cc species. For this purpose, 2D 1H-15N HSQC experiments were run using Cc samples in 
95% buffer and 5% D2O, or 100% D2O. 
NMR data processing was carried out using the Bruker TopSpin software package. The 
assignments of 2D and 3D spectra were performed manually with the help of the CARA and 
SPARKY software packages (18, 19). A list of NOEs of reduced yeast Cc was used as a 
reference (20). Final reviews of peak assignments and integrations of peak volumes were 
executed by the XEASY software (21). 15N relaxation parameters were analyzed using 
CARA routines (19).  
NMR titrations of 100 M 15N-labeled, reduced Y48pCMF Cc with aliquots of unlabeled, 
reduced plant cytochrome c1 (Cc1) were performed at 25ºC and recorded on a Bruker 
Avance 700 MHz. Titrations were performed in 5 mM sodium phosphate (pH 6.3) with 10% 
6 
D2O. Each titration step was prepared in an independent NMR tube (Shigemi) up to a 0.28 
mL final volume. The pH of the samples was checked before and after recording each 
spectrum. The Chemical-Shift Perturbations (CSP) were monitored in a series of 1H-15N 
HSQC experiments. The data were processed using Bruker TopSpin and analyzed with 
SPARKY (18). CSP titration curves were analyzed with Origin 7 (OriginLab, 
http://www.originlab.com), using a two-parameter non-linear least squares ﬁt with two-site 
binding model, as previously described (3, 4).  
 
Distance geometry calculations 
Volumes of cross-peaks between assigned resonances were obtained using the integration 
routines of the XEASY program. Elliptical integration was applied. NOESY cross-peak 
intensities were converted into upper limits of inter-atomic distances by CYANA (22). The 
heme group, axial ligands and two Cys residues covalently linked to the porphyrin ring were 
treated as in previous computations (23). Upper and lower distance limits were imposed to 
build up the heme group. Upper (1.90 Å) and lower (1.70 Å) distance limits from the -
carbons of thioethers 2 and 4 of the heme moiety to the Sof cysteines 14 and 17, 
respectively, were used in the computations to covalently link the heme moiety to the 
cysteine residues. An upper distance limit of 2.50 Å and a lower distance limit of 2.20 Å 
between the S of Met80 and the heme iron atom were also introduced. The orientations of 
Met80 and His18 side-chains were defined only by experimental NOE constraints. 
A residue containing the heme moiety was added to the standard CYANA library. In addition, 
the non-standard amino acid pCMF was built and added to the CYANA library. Several 
cycles of structure calculation were carried out in order to recalibrate the NOE distance 
constraints. CYANA calculations were performed following the procedure and with the 
parameters used for the determination of other c-type cytochromes (20, 24, 25). Initially, 200 
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structures were calculated. In each calculation, violated constraints were analyzed for the 
20 best structures with respect to the target function. After consecutive rounds of review and 
refinement of violated constraints, a final CYANA computation was performed in which no 
consistent violations were determined. The final average value of the target function was 
equal to 0.73 ± 018. 
 
Molecular dynamics simulations  
NMR-restrained Molecular Dynamics (RMD) computations were performed by the AMBER 
12.1 package and using the AMBER-2003 force field on a selection of the 20-best structures 
derived from the CYANA calculations (26, 27). Distance constraints were introduced by the 
DIS_RST module of Amber 12.1. Simulations were performed under periodic boundary 
conditions using an orthorhombic cell geometry (with the minimum distance between protein 
and cell faces initially set to 10 Å) and particle mesh Ewald (PME) electrostatics with a Ewald 
summation cut off of 9 Å. The structures were solvated with extended simple point charge 
model (SPC) water molecules, and Cl– counterions were added to neutralize the net charge 
of the full systems. Afterwards, solvent and counterions were subjected to 2500 steps of 
steepest descent minimization followed by 500 ps NPT-MD computations using isotropic 
molecule position scaling and a pressure relaxation time of 2 ps at 298 K. Once the systems 
were NMR-restrained energy minimized (REM), the resulting data were submitted to RMD 
computations for 5 ns at 298 K. The temperature was regulated using a Langevin thermostat 
with a collision frequency of 5 ps–1 (28). Finally, structures from RMD were energy minimized 
for 5000 steps. The SHAKE algorithm was used to constrain bonds involving hydrogen 
atoms (29). The PTRAJ module of AMBER was used for trajectory analyses. Force field 
parameters for the heme group were taken from a previous work (30). The Met80 residue 
was non-bonded to the iron atom and a constraint was applied instead. Molecular graphics 
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were performed with UCSF Chimera (31). Final minimized structures were validated by the 
Protein Structure Validation Software suite (PSVS) (32), the iCING server (33) and the 
Protein Data Bank (PDB) validation suite. In addition, a non-restrained MD computation of 
20 ns was launched to check the stability of the resulting conformers. A non-restrained MD 
computation of 20 ns was also launched on the NMR structure of WT Cc. S2 parameters 
values per residue were obtained from the non-restrained computations performed for both 
Cc species. 
Finally, NMR assignments and PDB coordinates for the Y48pCMF Cc were deposited in the 
Biological Magnetic Resonance Data Bank (BMRB) and PDB databases. BMRB and PDB 
entries for the Y48pCMF Cc are 25660 and 2N3Y, respectively.  
 
X-ray absorption spectroscopy  
X-ray absorption spectroscopy (XAS) experiments were carried out at Diamond Light Source 
(UK), operating at 3 GeV and 300 mA ring current. The Fe K-edge (7112 eV) was measured 
at beamline I20-scanning, comprising a four-bounce Si(111) crystal monochromator. Two 
Rh-coated mirrors working at 5.0 mrad were used for high-energy harmonics rejection. The 
spectra were recorded in fluorescence mode, using a 36-element monolithic Ge detector 
(Canberra). An iron foil was simultaneously recorded in transmission mode using ionization 
chamber detectors to be used as internal calibration. To avert radiation damage, X-rays 
were attenuated with a 1.5-mm thick carbon foil. In addition, samples were measured at 
cryogenic temperatures using a liquid nitrogen cryojet (Oxford Instrument). Each datapoint 
was collected using a 1 s acquisition time, and 36 scans were averaged. Samples were 
measured in plastic capillary cells. 350 M reduced Cc samples were prepared in 10 mM 
sodium phosphate buffer (pH 5.8).  
9 
Spectra averaging, background subtraction and amplitude normalization required to obtain 
the extended X-ray absorption fine structure (EXAFS) signals (k) were performed using the 
Athena (version 0.9.024) code (34). The best fit to the data was performed by using the 
Artemis program (version 0.9.024) (34). Scattering paths were computed using FEFF 6.0. 
Initial atomic coordinates of the heme moiety were taken from the crystallographic structure 
of the WT form (PDB: 3zcf) (35). Neither the initial coordinates from this structure nor those 
from the NMR structure (PDB: 1j3s) (36) yielded acceptable fits. Still, the distances coming 
out from these fits were used as input to screen 104 coordinates from each MD computation 
(2). The snapshots with the smallest sum of quadratic distance differences with respect to 
the EXAFS fit-derived distances were selected iteratively. 
  
Isothermal titration calorimetry  
Interactions of the human Cc species with plant Cc1, at their reduced and oxidized states 
were analyzed by isothermal titration calorimetry (ITC) using an Auto-ITC200 
microcalorimeter (MicroCal) at 25 °C. The reference cell was filled with distilled water. The 
experiments consisted of 2 L injections of 0.4 mM Cc solution in 10 mM sodium phosphate 
buffer (at pH 5.8, 7.4 and 8.5) into the sample cell, initially containing 20 M Cc1 solution in 
the same buffer. All solutions were degassed before titration. Titrant was injected at 
appropriate time intervals to ensure that the thermal power signal returned to the baseline 
prior to the next injection. To achieve a homogeneous mixing in the cell, the stirring speed 
was kept constant at 1000 rpm. The data, specifically the heat-per-injection normalized per 
mol of injectant versus molar ratio, were analyzed with Origin 7 (OriginLab) using a two-site 
binding model with a distinct affinity for each site, as recently reported for the plant Cc-Cc1 
complex (4). In addition, the titration of reduced bovine CcO (3.85 M) with the reduced Cc 
species (0.10 mM) was performed in 10 mM sodium phosphate buffer (pH 7.4), 
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supplemented with 0.2% (w/v) n-dodecyl--D-maltoside and 5 mM sodium dithionite, as 
described previously (3). ITC experiments were repeated at least twice to confirm that the 
data were consistent. The titration of Cc onto buffer containing detergent yielded small 
invariable injection heats attributed to dilution. Calibration and performance tests of the 
calorimeter were carried out by conducting Ca+2-EDTA titrations with the solutions provided 
by the manufacturer.  
ITC assays were analyzed considering several models: single binding site, two identical 
independent binding sites and two different independent binding sites. 
Single binding site 
A single binding site for Cc is considered in Cc1 (or CcO). The total concentration of Cc and 
Cc1 (or CcO) in the cell after injection i was calculated as: 












where [Cc]0 and [Cc1]0 are the concentrations of Cc in the syringe and the initial 
concentration of Cc1 (or CcO) in the cell, v is the injection volume, and V0 is the cell volume. 
Mass conservation principle and chemical equilibrium allow writing a set of coupled 
equations for Cc and Cc1 (or CcO): 
[C𝑐]𝑇 = [C𝑐] + [C𝑐1: C𝑐] = [C𝑐] + 𝐾𝐴[C𝑐1][C𝑐]
[C𝑐1]𝑇 = [C𝑐1] + [C𝑐1: 𝐶𝑐] = [C𝑐1] + 𝐾𝐴[C𝑐1][𝐶𝑐]
 
where KA is the equilibrium association constant for the complex Cc1:Cc (or CcO:Cc). These 
two equations can be transformed into a single equation in [Cc]: 





which is a quadratic polynomial equation that can be solved at each experimental point in 
the calorimetric titration in order to find the concentration of free Cc. Then, the concentration 
of complex Cc1:Cc (or CcO:Cc) after each injection can be calculated: 




Finally, the titrant-normalized heat effect associated with each injection i can be calculated 









) + 𝑞𝑑 
where H is the interaction enthalpy, and qd is an additional parameter accounting for the 
background (or dilution) heat. Non-linear least-square regression analysis of the 
experimental data using the previous equation provides an estimation of the binding 
parameters. 
Two independent binding sites 
Two independent binding sites for Cc are considered in in Cc1 (or CcO). The total 
concentration of Cc and in Cc1 (or CcO) in the cell after injection i was calculated as: 












where [Cc]0 and [Cc1]0 are the concentration of Cc in the syringe and the initial concentration 
of Cc1 (or CcO) in the cell, v is the injection volume, and V0 is the cell volume. Mass 
conservation principle and chemical equilibrium allow writing a single equation in [Cc]: 







where KA1 and KA2 are the equilibrium association constants for the complexes Cc1:Cc (or 
CcO:Cc) and Cc:Cc1 (or Cc:CcO). This is a cubic polynomial equation that can be solved 
(numerically) at each experimental point in the calorimetric titration in order to find the 
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concentration of free Cc. Then, the concentration of complexes Cc1:Cc (or CcO:Cc) and Cc: 
Cc1 (or Cc:CcO) after each injection can be calculated: 
[C𝑐1: C𝑐] = [C𝑐1]𝑇
𝐾𝐴1[C𝑐]
1 + 𝐾𝐴1[C𝑐]




Finally, the titrant-normalized heat effect associated with each injection i can be calculated 
from the net increase of complexes Cc1:Cc (or CcO:Cc) and Cc:Cc1 (or Cc:CcO) 















)) + 𝑞𝑑 
where H1 and H2 are the interaction enthalpies for each binding site. Non-linear least-
square regression analysis of the experimental data using the previous equation provides 
estimates of the binding parameters. 
This model corresponds to two identical independent binding sites when it is imposed that 
KA1 = KA2 and H1 = H2. 
C-values calculated using the KD values of the proximal site in the Y48pCMF Cc-involving 
titrations (Tables S5 and S6) are in the range of values allowed (1 < C < 1000). 
Calorimetric liposome binding assays were carried out in a low-volume Nano-ITC (TA 
instruments, Inc.). All titrations were performed in 25 mM HEPES buffer (pH 7.4). A 6 M Cc 
solution, previously reduced by an excess of sodium ascorbate that was further removed by 
dialysis, was titrated with a suspension of unilamellar liposomes. Stirring was set to 350 rpm. 
Unilamellar liposomes contained 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) either 
alone or with 1,1’2,2’-tetraoleoylcardiolipin (TOCL) at a 4:1 ratio. Total lipid concentration in 
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the syringe was 8.9 mM. DOPC unilamellar liposomes (7.9 mM) were used for control 
experiments. All ITC samples were previously degassed allowing Cc species to remain 
reduced in the syringe. In addition, Cc-liposome binding assays were performed under 
aerobic conditions, as reported in ref. (37). In such binding assays, each liposome could 
accommodate several Cc molecules. Data processing and analyses were carried out with 
the Nanoanalyze software (TA Instruments).  
 
Cytochrome c oxidase assays 
The ability of Cc species to act as electron donors for cytochrome c oxidase (CcO) activity 
was tested in isolated complex IV and in mitochondria from Saccharomyces cerevisiae. Two 
yeast cell strains were used for mitochondria extraction, namely WT (BY4741; MATa; 
ura30; leu20; his31; met150) (WTmito) and Cc-deficient Y06846 (BY4741; MATa; 
ura30; leu20; his31; met150; YJR048w::kanMX4) (Cc) strains. Two other yeast cell 
strains were likewise used for mitochondria extraction, namely WT (W303-1A; mata leu2 
trp1 ura3 his3 ade2) (WTRcf) and Rcf-deficient RCF1::HIS3 RCF2::KAN (W303-1A; mata 
leu2 trp1 ura3 ade2) (Rcf1/2) strains. WTmito and Cc cells were grown in YPD medium 
(1% yeast extract, 2% peptone and 2% glucose), whereas WTRcf and Rcf1/2 cells were 
grown in YPD medium or YP-0.5% lactate medium supplemented with 2% galactose (YP-
Gal), as described previously (38), to obtain mitochondria-enriched cells. In all cases, crude 
mitochondria were isolated as previously described (39) and stored at –80oC in 0.6 M 
sorbitol, 20 mM K-MES buffer (pH 6.0). The CcO activity was measured 
spectrophotometrically (Beckman DU® 650 spectrophotometer) using the commercial CcO 
activity kit from Sigma®, according to the manufacturer’s instructions. The kit uses a 
colorimetric assay based on observation of the decrease in absorbance at 550 nm caused 
by oxidation of ferro-Cc to ferri-Cc by CcO. The WT and Y48pCMF recombinant forms of 
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human Cc herein used (rather than Cc provided with the Sigma kit) were used. It was also 
tested that endogenous Cc from WTmito, WTRcf and Rcf1/2 mitochondria did not affect the 
CcO assay. To facilitate the interpretation of experimental findings, the relative CcO 
activities were represented upon normalization of the data obtained with Y48pCMF to those 
with WT Cc. In experiments with HIGD1A/2A proteins, the reaction mixtures were incubated 
at 25 ºC for 30 min before running the assay. Oxygen consumption rates were measured 
with an Oxygraph system (Hansatech) in the presence of 1 mM sodium ascorbate. A control 
trace (CcO in the presence of sodium ascorbate) was subtracted from the experimental data. 
 
Liposome preparation and binding experiments 
In order to analyze the interaction of the reduced Cc species with cardiolipin (CL), small 
unilamellar liposomes were prepared by sonication in 25 mM HEPES buffer (pH 7.4). 
Liposomes contained either DOPC and TOCL (4:1 ratio) or DOPC alone (manufactured by 
Avanti Polar Lipids®). The diameter of liposomes was 27.5 ± 10.8 nm, as inferred by 
Dynamic Light Scattering measurements. Cc:liposome binding assays were performed by 
incubating the Cc species with DOPC or TOCL/DOPC liposomes at different ratios 
(protein:lipids) for 1 h in 25 mM HEPES buffer (pH 7.4). The complexes were analyzed by 
electrophoretic mobility shift assay (EMSA). The samples were applied onto 0.8% agarose 
gel, and the electrophoresis was run for 90 min at 50 V in non-denaturing 35 mM HEPES 
buffer (pH 7.4). Gels were stained for protein detection with 0.25% Coomassie Brilliant Blue 
R-250 in 45% methanol and 10% acetic acid. 
 
Peroxidase assays 
Peroxidase assays of Cc:liposomes were performed as previously described with minor 
modifications (40). TOCL/DOPC liposomes were incubated for 1 h at room temperature with 
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reduced Cc (1 M) in a 1:100 ratio (w/w) (protein:lipid) in 20 mM HEPES buffer  (pH 7.4). 
After incubation, and immediately before starting the measurement, 2,7-dichlorofluorescin 
diacetate (H2DCF) and H2O2 were added to the samples at 5 M and 100 M final 
concentrations, respectively. Increases in DCF fluorescence at 522 nm were recorded along 
30 min upon excitation at 502 nm, with 5-nm slits, in a Cary Eclipse (Varian) fluorescence 
spectrophotometer. Basal peroxidase activity of Cc in CL-free liposomes was used as 
control. 
 
Caspase activation assays 
In vitro activation of caspases was achieved as described previously with minor 
modifications (41). Human embryonic kidney 293 (HEK 293) cytoplasmic cell extract (100 
g), prepared as described previously (42), was incubated for 60 min at 37oC, in a total 
volume of 25 L, with 25 mM KCl, 0.2 mM DTT, 0.2 mM dATP and human WT or Y48pCMF 
Cc at a final concentration of 8 M. After incubation, 180 L of buffer A (10 mM HEPES 
buffer (pH 7.0) with 50 mM NaCl, 40 mM -glycerophosphate, 2 mM MgCl2, 5 mM EGTA, 
0.1 mg mL–1 bovine serum albumin, and 0.1% (w/v) CHAPS), supplemented with 10 M of 
acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (Ac-DEVD-AMC; a fluorescent 
substrate specific for caspases 3/7), was added to the reaction mixture. Fluorescence 
increases resulting from Ac-DEVD-AMC cleavage was rapidly determined in a Cary Eclipse 
(Varian) fluorescence spectrophotometer (optical slits of 2.5 nm), using an excitation 
wavelength of 360 nm and an emission wavelength of 460 nm. Data were the averages of 
at least three independent experiments. 
 
Blue-native gel electrophoresis of protein complexes from yeast mitochondria 
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Fresh mitochondria (400 μg of protein) isolated from yeast cell extracts were permeabilized 
in 40 L of solubilization buffer (30 mM HEPES buffer (pH 7.4), with 150 mM KOH-acetate, 
10% glycerol and 1 mM PMSF) plus digitonin at a 4:1 (w:w) ratio of digitonin:protein. 
Samples were incubated on ice for 30 min, centrifuged for 30 s, and loaded onto 
NativePAGE Novex 3–12% Bis-Tris protein gel (1.0 mm, 15-well; Thermo Fisher Scientific, 
cat. No. BN2012BX10), following the manufacturer’s instructions. 
 
Antibodies 
Mouse monoclonal anti-His6 and anti--tubulin were obtained from Sigma-Aldrich (catalog 
numbers 11922416001 and T8328, respectively). Secondary horseradish peroxidase 
(HRP)-conjugated anti-mouse IgG was obtained from Sigma-Aldrich (catalog number 
A4416). Rabbit antibody against yeast Cc, and mouse antibody again yeast COX II, were a 
gift from Dr. Carlos Santos-Ocaña. Rabbit antibodies against the C-terminal domains of 
yeast Rcf1 and Rcf2 were kindly provided by Prof. Peter Rehling. Rabbit antiserum against 
yeast Cc1 was a gift from Prof. Nikolaus Pfanner. Rabbit anti-human Cc serum was obtained 
by immunizing male rabbits with full-length recombinant Cc suspended in a 0.85% NaCl 
solution. Secondary horseradish peroxidase (HRP)–conjugated anti-rabbit IgG was 
obtained from Sigma-Aldrich (catalog number A0545). 
 
Western blot analysis 
For immunoblot detection of yeast Cc, Rcf1 and Rcf2 in mitochondria and human Cc and -
tubulin in cytoplasmic fractions of HEK293 cells, protein quantification was first assessed 
using the Bradford protein assay (43). For immunodetection of Cc1, COX II, Rcf1 and Rcf2 
inside the respiratory supercomplexes, mitochondrial content were obtained after 
permeabilization and protein quantification by the Bradford protein assay (43). For 
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cytoplasmic cell extracts and mitochondria samples, 10–20 g of proteins were resolved by 
-dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE). For supercomplexes 
analysis, 20-g protein samples were loaded onto NativePAGE Novex 3–12% Bis-Tris 
protein gels (1.0 mm, 15-well; Thermo Fisher Scientific, catalog number BN2012BX10), 
which were further transferred to polyvinylidene fluoride (PVDF) membranes (EMD Millipore) 
using a Mini Trans-Blot electrophoretic transfer cell (Bio-Rad). Membranes were blocked in 
5% nonfat dry milk in PBS with Tween-20 (TPBS) for cytoplasmic extracts and mitochondria, 
and in only TBS for supercomplex analyses. Immunoblots were performed with primary 
antibodies, and then HRP-conjugated secondary antibodies were used for detection. The 
immunoreactive bands were detected using Amersham ECL Plus Western Blotting 






Table S1. NMR experiments performed on reduced Y48pCMF Cc 
 Experiments Magnetic Field 
Backbone assignment 
2D 1H-15N HSQC, 2D 1H-13C 
HSQC, 3D HNCA, 3D 
HNCACB, 3D 
CBCA(CO)NH, 3D 
HN(CA)CO and 3D HNCO. 
700 MHz 
Side-chain assignment 
2D 1H-13C HSQC, 2D   
COSY, 3D HBHA(CO)NH 
and 3D HCCH-TOCSY. 
700 MHz 
Aromatic 2D 1H-13C HSQC 500 MHz 
Mobility analysis 
15N R1, 15N R2 and steady-
state {1H}-15N NOE 
500 MHz 
Distance constraints 
2D 1H-1H NOESY, 3D 1H-
15N  NOESY-HSQC, 3D 1H-
13C NOESY-HSQC 
950 MHz 
Heme assignments & 
constraints 
2D  COSY, 2D 1H-15N 




2D 1H-15N HSQC 700 MHz 






Table S2. NMR statistics of the Y48pCMF Cc structure 
 
NMR distance and dihedral constraints 
Distance constraints  
       Total meaningful NOE 2,176 
       Intra-residue 360 
       Inter-residue 1,816 
       Sequential (|i – j| = 1) 763 
       Medium-range (|i – j| ≤ 5) 539 
       Long-range (|i – j| > 5) 514 
  Total dihedral angle restraints  
        71 
        71 
Structure statistics 
Violations  
      Average target function 0.73 ± 0.18 
      Distance constraints (Å) 0.0059 ± 0.0014 
      Dihedral angle constraints (º)     0.3336 ± 0.0973 
      Max. distance constraint violation (Å) 0.29 
      Max. dihedral angle violation (º) 3.79 
RMSD of minimized 20 conformers to the mean (Å)  
      Backbone 0.89 ± 0.01 
      Heavy atoms 1.33 ± 0.24 
Global RMSD of minimized 20 conformers (Å)  
      Backbone 1.28 ± 0.30 
      Heavy atoms 1.91 ± 0.38 
  Ramachandram plot statistics from Procheck  
      Residues in favoured regions (%)       98.80 ± 0.10 
      Residues in generously allowed regions (%) 1.00 ± 0.10 
      Residues in disallowed regions (%) 0.20 ± 0.10 
  Global quality  
      Procheck G-factor (all dihedrals, raw score)      -0.436 ± 0.046 
      Verify 3D 0.432 ± 0.030 
      Prosall 0.578 ± 0.047 
      MolProbity Clashscore       2.564 ± 1.263 
      Number of close contacts 0 












Table S3. EXAFS fits of the Y48pCMF Cc structure 
 
 Paths 2path (Å2) R (Å) E0 (eV) 
WT NPi 0.0012 ± 0.0006 1.983 ± 0.008 0.5 ± 1.0 
NIz 0.0011 2.214 
S 0.002 ± 0.002 2.26 ± 0.01 
CPi 
0.002 ± 0.001 
2.98 
3.02 ± 0.01 
3.06 
Pi Multiple 0.002  
Y48pCMF NPi 0.003 ± 0.001 1.990 ± 0.001 0.4 ± 1.3 
NIz 0.0011 2.21 
S 0.003 ± 0.002 2.25 ± 0.01 
CPi 
0.002 ± 0.001 
2.99 
3.03 ± 0.02 
3.06 
Pi Multiple 0.003  
*The amplitude reduction factor, S02, was set to 1.0 for all fits. kWT = 1.389 ─ 11.885 Å-1; 
kY48pCMF = 1.358 ─ 11.685 Å-1; RWT = 1.15 ─ 2.95 Å; RY48pCMF = 1.18 ─ 2.95 Å. Fit R 



















WT Cc Y48pCMF Cc Difference 
R1 (s–1) 2.26 ± 0.08 2.15 ± 0.07 0.11 
R2 (s–1) 8.53 ± 0.46 9.14 ± 0.48 0.61 
R2 / R1 3.77 ± 0.23 4.25 ± 0.23 0.48 
NOE ratio 0.80 ± 0.03 0.80 ± 0.02 0.00 





Table S5. Equilibrium and thermodynamic parameters for the interaction of WT and Y48pCMF Cc at the two binding sites of Cc1, 
as determined by ITC 
Relative errors: KD, 20%; H and –TS, 5%; G 2% 
1 = Ref. 3 
a = pH 7.4 
b = pH 5.8 
c = pH 8.5 
  



















Cc WTred/Cc1reda,1 11.5 11.7 –18.40 –6.70 54.0 10.5 –16.30 –5.80 2 
Cc Y48pCMFred/Cc1reda 5.1 –1.8 –5.42 –7.22 230.0 4.4 –9.36 –4.96 2 
Cc WTox/Cc1oxb 1.9 6.2 –14.00 –7.80 110.0 1.1 –6.50 –5.40 2 
Cc Y48pCMFox/Cc1oxb 1.8 8.2 –16.03 –7.83 71.0 3.3 –8.96 –5.66 2 
Cc WTox/Cc1oxc 50.0 4.3 –10.16 –5.86 140.0 0.8 –6.05 –5.25 2 





Table S6. Equilibrium and thermodynamic parameters for the interaction of WT and Y48pCMF Cc at the two binding sites of 
bovine CcO, as determined by ITC 
Relative errors: KD, 20%; H and –TS, 5%; G, 2% 
1 = Ref. 3.  
  



















Cc WTred/CcOred1 0.03 –6.6 –3.7     –10.3   0.30 –5.4 –3.5 –8.9 2 



















Figure S1. Chemical-shift differences between WT and Y48pCMF Cc. (a) Plot of the 
chemical-shift differences between both Cc species for backbone amides along their primary 
sequence. (b) The chemical shift differences are mapped on the Y48pCMF Cc surface 
according to the degree of change. Residues are colored in yellow if the chemical-shift 
difference ranged between 0.1 and 0.2 ppm, and in red if the difference was greater than 
0.2 ppm. Residues with undetectable backbone amide resonances in the 1H-15N HSQC 
spectrum of Y48pCMF Cc but detectable in WT Cc are colored in orange. pCMF48 and the 
heme group are given in black and green, respectively. Unaffected, unassigned and proline 






Figure S2. Number of experimental meaningful NOEs per residue used for the 
structure calculation of Y48pCMF Cc. The color code for the NOE bars is: intra-residue, 
white; sequential, light gray; medium, gray; and long range, black. Residue 105 corresponds 




















Figure S3. Molecular Dynamics simulations for the Y48pCMF variant and WT form of 
Cc. (a) A non-restrained MD computation was performed to check the stability of conformers 
derived from the NMR structure of Y48pCMF Cc. RMSD values are plotted along the full 20 
ns trajectory, considering either residues away from the mutation surroundings (black) or 
the whole protein sequence (blue). (b) Time evolution of secondary structural elements 
along the MD trajectory represented in (a). The color code is as follows: -helix, red; -helix, 
orange; extended -brand, blue; -bridge, cyan; turn, yellow; and coil, white. (c) Comparison 
of S2 order parameter values for Y48pCMF and WT Cc obtained from MD computations. S2 
order parameter values per residue for Y48pCMF (left) and WT (right) Cc are represented 
on their respective NMR ribbon structures using a blue-red scale (color key is shown). Heme 
atoms are in green. Heme axial ligands are also displayed. Internal mobility of alpha carbon 




















Figure S4: Folding units of WT Cc. Ribbon diagram of human WT Cc (PDB ID: 1J3S) (36), 




Figure S5. NMR data in combination with XAS measurements. (a) Per residue RMSD 
values between the first conformer of the NMR solution structures of WT Cc (PDB ID: 1J3S) 
(36) and the refined lowest-TF Y48pCMF Cc. Backbone and heavy atoms are represented 
as gray triangles and black circles, respectively. RMSD calculations were performed with 
the MOLMOL software (45). (b) Global RMSD values per residue of the best 20 conformers 
of Y48pCMF Cc with respect to the mean structure. The color code is as in (a). (c) Overlay 
of the X-ray absorption near-edge structure (XANES) regions of the X-ray Absorption 
Spectra (XAS) spectra of reduced WT (blue) and Y48pCMF (red) Cc. The inset displays an 
enlargement of the absorption edge. (d) Normalized XAS and Extended absorption fine 
Structure (EXAFS) waves of WT (blue) and Y48pCMF (red) Cc. Black dots correspond to 
the best fits summarized in Table S3. (e) Modulus of the Fourier transforms of the EXAFS 
signals for the reduced WT (continuous line, blue) and Y48pCMF (continuous line, red) Cc 
species. Dotted curves are the best fits of the experimental data carried out within the 
interval ΔR = 1.38–2.95 Å. (f) q-space, reverse Fourier transform of the experimental data 
















Figure S6. Relative orientation of Phe82 with respect to the heme moiety. The 
ensemble of the NMR structures from WT Cc (PDB CODE: 1J3S) (36) and the Y48pCMF 
mutant (this work) are represented in sticks. Heavy atoms except carbons are in CPK colors, 






Figure S7. Amide-hydrogen exchange experiments with WT and Y48pCMF Cc. (a) 1H-
15N HSQC spectrum of WT Cc recorded either in 95% H2O and 5% D2O (blue) or in 100% 
D2O (cyan). (b) 1H-15N HSQC spectrum of Y48pCMF Cc recorded either in 95% H2O and 
5% D2O (red) or in 100% D2O (gold). (c) Residues protected from amide-hydrogen exchange 
in both Cc species are displayed in gold, those protected only in Y48pCMF Cc, in red, and 
those protected only in WT Cc, in blue. pCMF48 and the heme group are in black and green, 
respectively. The representation is projected on the Y48pCMF Cc structure, whose surface 




Figure S8. (a,b) Surface electrostatic potentials of WT (a) and Y48pCMF (b) Cc 
molecules. Negatively and positively charged regions are depicted in red and blue, 
respectively. Simulations were performed with the DelPhi program (46) aided by Chimera 
(31), assuming an ionic strength of 250 mM. The color scale ranges from –5 (red) to +5 
(blue) kBT. Some residues were labelled to better show the orientation of both Cc species. 
The PDB file 1J3S was used for the WT Cc structure. 
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Figure S9. ITC isotherms for the interaction of the Y48pCMF Cc mutant with CcO. Solid 
squares represent experimental data, which are fitted to a 2:1 model using either two 




Figure S10. Standard CcO assays. a) Data in Figure 5a without normalization. CcO 
activities were measured by monitoring the absorption changes at 550 nm, as reported 
under Supplementary Methods. Activity units are mol Cc min-1. b) Oxygen consumption 
under the experimental conditions used for the spectrophotometric assays. 1 mM sodium 
ascorbate was added to the reaction mixture. A control trace obtained with sodium ascorbate 
was subtracted from the experimental data, which are in blue and red for WT and mutant 
Cc, respectively. The resulting oxygen consumption rates were calculated from the 





Figure S11. HIGD proteins. (a) SDS-PAGE of purified HIGD1A and HIGD2A His-tagged 
proteins after applying an imidazole gradient. M, molecular weight markers. The arrow points 
to the bands corresponding to HIGD proteins. (b) Western blot analysis using an antibody 
against His-tag to identify HIGD1A and HIGD2A following Ni-column purification. (c) Trypsin 
digestion of HIGD proteins followed by matrix-assisted laser desorption ionization with time-
35 
of-light (MALDI-TOF) analysis. (d) Tryptic digestion of proteins from BN-PAGE bands 
followed by MALDI-TOF/TOF and highlighted by asterisks in Figure 5D. Specifically, the 
data presented here correspond to the upper band in YP-Gal in Figure 5D. The expected 
tryptic masses clearly matched the calculated values, with 0.5 Da tolerance. The sequence 
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